Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 7, 2009; 15(21): 2651-2656
Published online Jun 7, 2009. doi: 10.3748/wjg.15.2651
Published online Jun 7, 2009. doi: 10.3748/wjg.15.2651
Table 1 Characteristics of patients, tumors and treatment approach (mean ± SD)
Patients and tumor characteristics | Value |
No. of patients | 255 |
Median age (yr) | 56.0 ± 13.2 (range, 18-89) |
Gender (male/female) | 205/50 |
Disease (HCC/MHC/CCC) | 212/39/4 |
Background liver disease (HBV/HCV/no infection) | 168/5/82 |
Patients with liver cirrhosis n (%) | 172 (67.5) |
Portal vein invasion (no/yes) | 25/230 |
Alphafetoprotein (0-5/5-400/> 400 ng/mL) | 88/92/75 |
Child-Pugh classification (A/B/C) | 231/22/2 |
ALT (U/L) | 47.6 ± 2.5 |
AST (U/L) | 54.7 ± 3.0 |
Total bilirubin (umol/L) | 27.4 ± 7.1 |
Serum albumin (g/L) | 38.9 ± 0.3 |
Tumor stage | 425 |
Number of tumors (uninodular/multinodular) | 148/107 |
Size of tumor (cm) | 5.1 ± 3.4 (range, 1.3- 20) |
Diagnosis (histopathologic/clinical) | 215/210 |
Treatment | 350 |
Choice of approach (percutaneous/ laparoscopy/laparotomy) | 257/7/86 |
Combination with TACE or PEI (+/-) | 61/194 |
- Citation: Kong WT, Zhang WW, Qiu YD, Zhou T, Qiu JL, Zhang W, Ding YT. Major complications after radiofrequency ablation for liver tumors: Analysis of 255 patients. World J Gastroenterol 2009; 15(21): 2651-2656
- URL: https://www.wjgnet.com/1007-9327/full/v15/i21/2651.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2651